Burial of the polymorphic residue 129 in amyloid fibrils of prion stop mutants

Journal of Biological Chemistry

Volumn 288, Issue 5, 2013, Pages 2994-3002

  Skora, Lukasz ^a   Fonseca Ornelas, Luis ^a   Hofele, Romina V ^a   Riedel, Dietmar ^a   Giller, Karin ^a   Watzlawik, Jens ^b   Schulz Schaeffer, Walter J ^b   Urlaub, Henning ^a,c   Becker, Stefan ^a   Zweckstetter, Markus ^a  

^a MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^b Prion and Dementia Research Unit   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID FIBRIL; CORE STRUCTURE; DATA SUPPORT; PRION DISEASE;

AMINO ACIDS; NEURODEGENERATIVE DISEASES;

GLYCOPROTEINS;

AMYLOID; METHIONINE; PRION PROTEIN; VALINE;

ARTICLE; GENE MUTATION; GENETIC POLYMORPHISM; MUTANT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN STRUCTURE; STOP CODON;

AMINO ACID SEQUENCE; AMYLOID; CENTRIFUGATION; CODON, TERMINATOR; HUMANS; METHIONINE; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; MUTATION; POLYMORPHISM, GENETIC; PRIONS; PROTEIN STRUCTURE, QUATERNARY; SOLVENTS;

EID: 84873313592     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.423715     Document Type: Article

References (51)

1. Aguzzi, A., Sigurdson, C., and Heikenwaelder, M. (2008) Molecular mechanisms of prion pathogenesis. Annu. Rev. Pathol. 3, 11-40
2. Parchi, P., Giese, A., Capellari, S., Brown, P., Schulz-Schaeffer, W., Windl, O., Zerr, I., Budka, H., Kopp, N., Piccardo, P., Poser, S., Rojiani, A., Streichemberger, N., Julien, J., Vital, C., Ghetti, B., Gambetti, P., and Kretzschmar, H. (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol 46, 224-233
3. Wemheuer, W. M., Benestad, S. L., Wrede, A., Schulze-Sturm, U., Wemheuer, W. E., Hahmann, U., Gawinecka, J., Schütz, E., Zerr, I., Brenig, B., Bratberg, B., Andréoletti, O., and Schulz-Schaeffer, W. J. (2009) Similarities between forms of sheep scrapie and Creutzfeldt-Jakob disease are encoded by distinct prion types. Am. J. Pathol. 175, 2566-2573
4. Parchi, P., Zou, W., Wang, W., Brown, P., Capellari, S., Ghetti, B., Kopp, N., Schulz-Schaeffer, W. J., Kretzschmar, H. A., Head, M. W., Ironside, J. W., Gambetti, P., and Chen, S. G. (2000) Genetic influence on the structural variations of the abnormal prion protein. Proc. Natl. Acad. Sci. U. S. A. 97, 10168-10172
5. Schulz-Schaeffer, W. J., Giese, A., Windl, O., and Kretzschmar, H. A. (1996) Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt-Jakob disease. Clin. Neuropathol 15, 353-357
6. Heinemann, U., Krasnianski, A., Meissner, B., Varges, D., Kallenberg, K., Schulz-Schaeffer, W. J., Steinhoff, B. J., Grasbon-Frodl, E. M., Kretzschmar, H. A., and Zerr, I. (2007) Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain 130, 1350-1359
7. Telling, G. C. (2011) Transgenic mouse models and prion strains. Top Curr. Chem. 305, 79-99
8. Wüthrich, K., and Riek, R. (2001) Three-dimensional structures of prion proteins. Adv. Protein Chem. 57, 55-82
9. Wille, H., Bian, W., McDonald, M., Kendall, A., Colby, D. W., Bloch, L., Ollesch, J., Borovinskiy, A. L., Cohen, F. E., Prusiner, S. B., and Stubbs, G. (2009) Natural and synthetic prion structure from x-ray fiber diffraction. Proc. Natl. Acad. Sci. U. S. A. 106, 16990-16995
10. Paramithiotis, E., Pinard, M., Lawton, T., La Boissiere, S., Leathers, V. L., Zou, W. Q., Estey, L. A., Lamontagne, J., Lehto, M. T., Kondejewski, L. H., Francoeur, G. P., Papadopoulos, M., Haghighat, A., Spatz, S. J., Head, M., Will, R., Ironside, J., O'Rourke, K., Tonelli, Q., Ledebur, H. C., Chakrabartty, A., and Cashman, N. R. (2003) Aprion protein epitope selective for the pathologically misfolded conformation. Nat. Med. 9, 893-899
11. Smirnovas, V., Baron, G. S., Offerdahl, D. K., Raymond, G. J., Caughey, B., and Surewicz, W. K. (2011) Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Nat. Struct. Mol. Biol. 18, 504-506
12. Govaerts, C., Wille, H., Prusiner, S. B., and Cohen, F. E. (2004) Evidence for assembly of prions with left-handed β-helices into trimers. Proc. Natl. Acad. Sci. U. S. A. 101, 8342-8347
13. Wille, H., Govaerts, C., Borovinskiy, A., Latawiec, D., Downing, K. H., Cohen, F. E., and Prusiner, S. B. (2007) Electron crystallography of the scrapie prion protein complexed with heavy metals. Arch Biochem. Biophys. 467, 239-248
14. Kunes, K. C., Clark, S. C., Cox, D. L., and Singh, R. R. (2008) Left handed β helix models for mammalian prion fibrils. Prion 2, 81-90
15. Lu, X., Wintrode, P. L., and Surewicz, W. K. (2007) β-Sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange. Proc. Natl. Acad. Sci. U. S. A. 104, 1510-1515
16. Nazabal, A., Hornemann, S., Aguzzi, A., and Zenobi, R. (2009) Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils. J. Mass Spectrom 44, 965-977
17. Damo, S. M., Phillips, A. H., Young, A. L., Li, S., Woods, V. L., Jr., and Wemmer, D. E. (2010) Probing the conformation of a prion protein fibril with hydrogen exchange. J. Biol. Chem. 285, 32303-32311
18. De Marco, M. L., and Daggett, V. (2004) From conversion to aggregation: protofibril formation of the prion protein. Proc. Natl. Acad. Sci. U. S. A. 101, 2293-2298
19. Tateishi, J., Kitamoto, T., Kretzschmar, H., and Mehraein, P. (1996) Immunohistological evaluation of Creutzfeldt-Jakob disease with reference to the type PrPres deposition. Clin. Neuropathol 15, 358-360
20. Kundu, B., Maiti, N. R., Jones, E. M., Surewicz, K. A., Vanik, D. L., and Surewicz, W. K. (2003) Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation. Proc. Natl. Acad. Sci. U. S. A. 100, 12069-12074
21. Vanik, D. L., Surewicz, K. A., and Surewicz, W. K. (2004) Molecular basis of barriers for interspecies transmissibility of mammalian prions. Mol. Cell 14, 139-145
22. Watzlawik, J., Skora, L., Frense, D., Griesinger, C., Zweckstetter, M., Schulz-Schaeffer, W. J., and Kramer, M. L. (2006) Prion protein helix1 promotes aggregation but is not converted into β-sheet. J. Biol. Chem. 281, 30242-30250
23. Jayadev, S., Nochlin, D., Poorkaj, P., Steinbart, E. J., Mastrianni, J. A., Montine, T. J., Ghetti, B., Schellenberg, G. D., Bird, T. D., and Leverenz, J. B. (2011) Familial prion disease with Alzheimer disease-like Tau pathology and clinical phenotype. Ann. Neurol 69, 712-720
24. Helmus, J. J., Surewicz, K., Nadaud, P. S., Surewicz, W. K., and Jaroniec, C. P. (2008) Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils. Proc. Natl. Acad. Sci. U. S. A. 105, 6284-6289
25. Helmus, J. J., Surewicz, K., Surewicz, W. K., and Jaroniec, C. P. (2010) Conformational flexibility of Y145Stop human prion protein amyloid fibrils probed by solid-state nuclear magnetic resonance spectroscopy. J. Am. Chem. Soc. 132, 2393-2403
26. Helmus, J. J., Surewicz, K., Apostol, M. I., Surewicz, W. K., and Jaroniec, C. P. (2011) Intermolecular alignment in Y145Stop human prion protein amyloid fibrils probed by solid-state NMR spectroscopy. J. Am. Chem. Soc. 133, 13934-13937
27. Liemann, S., and Glockshuber, R. (1999) Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 38, 3258-3267
28. Cho, M. K., Kim, H. Y., Fernandez, C. O., Becker, S., and Zweckstetter, M. (2011) Conserved core of amyloid fibrils of wild type and A30P mutant α-synuclein. Protein Sci. 20, 387-395
29. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293
30. Bax, A., and Grzesiek, S. (1993) Methodological advances in protein. Acc. Chem. Res. 26, 131-138
31. 15N) labeled proteins: application to unfolded proteins. J. Biomol. NMR 20, 135-147
32. Stejskal, E. O., and Tanner, J. E. (1965) Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J. Chem. Phys. 42, 288-292
33. Wu, D. H., Chen, A. D., and Johnson, C. S. (1995) An improved diffusionordered spectroscopy experiment incorporating bipolar-gradient pulses. J. Magn. Reson. A 115, 260-264
34. Sharp, J. S., Becker, J. M., and Hettich, R. L. (2003) Protein surface mapping by chemical oxidation: structural analysis by mass spectrometry. Anal. Biochem. 313, 216-225
35. Rappsilber, J., Ishihama, Y., and Mann, M. (2003) Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 75, 663-670
36. Cox, J., and Mann, M. (2008) MaxQuant enables high peptide identification rates, individualized p. p. b.-range mass accuracies, and proteomewide protein quantification. Nat. Biotechnol. 26, 1367-1372
37. Cox, J., Neuhauser, N., Michalski, A., Scheltema, R. A., Olsen, J. V., and Mann, M. (2011) Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794-1805
38. Charvátová, O., Foley, B. L., Bern, M. W., Sharp, J. S., Orlando, R., and Woods, R. J. (2008) Quantifying protein interface footprinting by hydroxyl radical oxidation and molecular dynamics simulation: application to galectin-1. J. Am. Soc. Mass Spectrom 19, 1692-1705
39. Perrin, F. (1934) Brownian motion of an ellipsoid. I. Dielectric dispersion for ellipsoidal molecules. J. Phys. Radium 5, 497-511
40. 2-microglobulin amyloid fibril by H/D exchange. Nat. Struct. Biol. 9, 332-336
41. Xu, G., and Chance, M. R. (2007) Hydroxyl radical-mediated modification of proteins as probes for structural proteomics. Chem. Rev. 107, 3514-3543
42. Breydo, L., Bocharova, O. V., Makarava, N., Salnikov, V. V., Anderson, M., and Baskakov, I. V. (2005) Methionine oxidation interferes with conversion of the prion protein into the fibrillar proteinase K-resistant conformation. Biochemistry 44, 15534-15543
43. Ghetti, B., Piccardo, P., Spillantini, M. G., Ichimiya, Y., Porro, M., Perini, F., Kitamoto, T., Tateishi, J., Seiler, C., Frangione, B., Bugiani, O., Giaccone, G., Prelli, F., Goedert, M., Dlouhy, S. R., and Tagliavini, F. (1996) Vascular variant of prion protein cerebral amyloidosis with Tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc. Natl. Acad. Sci. U. S. A. 93, 744-748
44. Jansen, C., Parchi, P., Capellari, S., Vermeij, A. J., Corrado, P., Baas, F., Strammiello, R., van Gool, W. A., van Swieten, J. C., and Rozemuller, A. J. (2010) Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP. Acta Neuropathol 119, 189-197
45. Tagliavini, F., Prelli, F., Ghiso, J., Bugiani, O., Serban, D., Prusiner, S. B., Farlow, M. R., Ghetti, B., and Frangione, B. (1991) Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58. EMBO J. 10, 513-519
46. Wopfner, F., Weidenhöfer, G., Schneider, R., von Brunn, A., Gilch, S., Schwarz, T. F., Werner, T., and Schätzl, H. M. (1999) Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J. Mol. Biol. 289, 1163-1178
47. Hölscher, C., Delius, H., and Bürkle, A. (1998) Overexpression of nonconvertible PrPc 114-121 in scrapie-infected mouse neuroblastoma cells leads to trans-dominant inhibition of wild-type PrPSc accumulation. J. Virol. 72, 1153-1159
48. Skora, L., and Zweckstetter, M. (2012) Determination of amyloid core structure using chemical shifts. Protein Sci. 21, 1948-1953
49. Jones, E. M., Surewicz, K., and Surewicz, W. K. (2006) Role of N-terminal familial mutations in prion protein fibrillization and prion amyloid propagation in vitro. J. Biol. Chem. 281, 8190-8196
50. Palmer, M. S., Dryden, A. J., Hughes, J. T., and Collinge, J. (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352, 340-342
51. Tahiri-Alaoui, A., Gill, A. C., Disterer, P., and James, W. (2004) Methionine 129 variant of human prion protein oligomerizes more rapidly than the valine 129 variant: implications for disease susceptibility to Creutzfeldt-Jakob disease. J. Biol. Chem. 279, 31390-31397